Literature DB >> 33692798

Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy.

Kazuko Tajiri1, Saori Yonebayashi1, Siqi Li1, Masaki Ieda1.   

Abstract

Accumulating evidence suggests that the breakdown of immune tolerance plays an important role in the development of myocarditis triggered by cardiotropic microbial infections. Genetic deletion of immune checkpoint molecules that are crucial for maintaining self-tolerance causes spontaneous myocarditis in mice, and cancer treatment with immune checkpoint inhibitors can induce myocarditis in humans. These results suggest that the loss of immune tolerance results in myocarditis. The tissue microenvironment influences the local immune dysregulation in autoimmunity. Recently, tenascin-C (TN-C) has been found to play a role as a local regulator of inflammation through various molecular mechanisms. TN-C is a nonstructural extracellular matrix glycoprotein expressed in the heart during early embryonic development, as well as during tissue injury or active tissue remodeling, in a spatiotemporally restricted manner. In a mouse model of autoimmune myocarditis, TN-C was detectable before inflammatory cell infiltration and myocytolysis became histologically evident; it was strongly expressed during active inflammation and disappeared with healing. TN-C activates dendritic cells to generate pathogenic autoreactive T cells and forms an important link between innate and acquired immunity.
Copyright © 2021 Tajiri, Yonebayashi, Li and Ieda.

Entities:  

Keywords:  autoimmunity; extracellular matrix; inflammatory cardiomyopathy; myocarditis; tenascin-C

Year:  2021        PMID: 33692798      PMCID: PMC7938317          DOI: 10.3389/fimmu.2021.624703

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  67 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation.

Authors:  Bin Tsukada; Fumio Terasaki; Hiroaki Shimomura; Koji Otsuka; Kaoru Otsuka; Takashi Katashima; Shuichi Fujita; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Michiaki Hiroe; Yasushi Kitaura
Journal:  Hum Pathol       Date:  2009-03-17       Impact factor: 3.466

4.  Mice develop normally without tenascin.

Authors:  Y Saga; T Yagi; Y Ikawa; T Sakakura; S Aizawa
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

5.  Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.

Authors:  Urs Eriksson; Romeo Ricci; Lukas Hunziker; Michael O Kurrer; Gavin Y Oudit; Tania H Watts; Ivo Sonderegger; Kurt Bachmaier; Manfred Kopf; Josef M Penninger
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

6.  High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy.

Authors:  Thomas Schenk; Martin Enders; Stefan Pollak; Ralph Hahn; Daniela Huzly
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

7.  Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease.

Authors:  Mikio Shiba; Yasuo Sugano; Yoshihiko Ikeda; Hideshi Okada; Toshiyuki Nagai; Hatsue Ishibashi-Ueda; Satoshi Yasuda; Hisao Ogawa; Toshihisa Anzai
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 8.  Myocarditis in Humans and in Experimental Animal Models.

Authors:  Przemysław Błyszczuk
Journal:  Front Cardiovasc Med       Date:  2019-05-16

9.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).

Authors:  Tao Guo; Yongzhen Fan; Ming Chen; Xiaoyan Wu; Lin Zhang; Tao He; Hairong Wang; Jing Wan; Xinghuan Wang; Zhibing Lu
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

Review 10.  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.

Authors:  Carsten Tschöpe; Enrico Ammirati; Biykem Bozkurt; Alida L P Caforio; Leslie T Cooper; Stephan B Felix; Joshua M Hare; Bettina Heidecker; Stephane Heymans; Norbert Hübner; Sebastian Kelle; Karin Klingel; Henrike Maatz; Abdul S Parwani; Frank Spillmann; Randall C Starling; Hiroyuki Tsutsui; Petar Seferovic; Sophie Van Linthout
Journal:  Nat Rev Cardiol       Date:  2020-10-12       Impact factor: 49.421

View more
  2 in total

1.  MiR-495-3p depletion contributes to myocardial ischemia/reperfusion injury in cardiomyocytes by targeting TNC.

Authors:  Wei Song; Naiyan Qiu
Journal:  Regen Ther       Date:  2022-09-12       Impact factor: 3.651

Review 2.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.